Viewing StudyNCT01658462



Ignite Creation Date: 2024-05-06 @ 12:47 AM
Last Modification Date: 2024-10-26 @ 10:54 AM
Study NCT ID: NCT01658462
Status: COMPLETED
Last Update Posted: 2019-05-31
First Post: 2012-07-31

Brief Title: Phase II Study of Docetaxel - Nintedanib in Breast Cancer
Sponsor: Centre Oscar Lambret
Organization: Centre Oscar Lambret

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
locally recurrent or metastatic breast cancer View
Docetaxel View
Nintedanib View